NASDAQ:XFOR

X4 Pharmaceuticals Stock Forecast

etoro logo Buy XFOR
*Your capital is at risk
$4.00
+0.0700 (+1.78%)
At Close: Jul 29, 2026
AI Analysis AI Analysis of XFOR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add XFOR to Watchlist?
Some Reasons Why To Add XFOR:
  • +126.0% price growth over the last year
  • High gross margin of 79.4%
  • Lower volatility than the market (beta 0.35)
PDF

X4 Pharmaceuticals Inc. stock upgraded to Buy Candidate
(Updated on Jul 29, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jul 29, 2026

The X4 Pharmaceuticals Inc. stock price gained 1.78% on the last trading day (Wednesday, 29th Jul 2026), rising from $3.93 to $4.00. During the last trading day the stock fluctuated 4.90% from a day low at $3.88 to a day high of $4.07. The price has been going up and down for this period, and there has been a 2.56% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 868 thousand shares were bought and sold for approximately $3.47 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -4.99% during the next 3 months and, with a 90% probability hold a price between $3.47 and $4.36 at the end of this 3-month period.

XFOR Signals & Forecast

The X4 Pharmaceuticals Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $3.87 and $4.00. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 8.70%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for X4 Pharmaceuticals Inc. stock

X4 Pharmaceuticals Inc. finds support from accumulated volume at $3.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.190 between high and low, or 4.90%. For the last week, the stock has had daily average volatility of 6.75%.

Our recommended stop-loss: $3.84 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)

Trading Expectations (XFOR) For The Upcoming Trading Day Of Thursday 30th

For the upcoming trading day on Thursday, 30th we expect X4 Pharmaceuticals Inc. to open at $3.98, and during the day (based on 14 day Average True Range), to move between $3.88 and $4.12, which gives a possible trading interval of +/-$0.244 (+/-6.30%) up or down from last closing price. If X4 Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 6.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.99 (0.25%) than the resistance at $4.02 (0.50%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

X4 Pharmaceuticals Inc. will release earnings BMO on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is -$0.190. We will update the financials statements for X4 Pharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 17.56% in the first trading day after earnings release.

Is X4 Pharmaceuticals Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 3.041 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 30, 2026 - $3.98 ( 0.417%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

XFOR Performance

Trading levels for XFOR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.17 4.33%
R2 4.10 2.52%
R1 4.06 1.40%
Price 4.00
S1 3.91 -2.23%
S2 3.87 -3.35%
S3 3.79 -5.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.67 16.75%
R2 4.04 1.00%
R1 4.02 0.500%
Price 4.00
S1 3.99 -0.250%
S2 3.94 -1.50%
S3 3.68 -8.00%

FAQ

What is the symbol for X4 Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for X4 Pharmaceuticals Inc. is XFOR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell X4 Pharmaceuticals Inc. Stock?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy X4 Pharmaceuticals Inc. Stock?
X4 Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy X4 Pharmaceuticals Inc. Stock.

What's the current price of X4 Pharmaceuticals Inc. Stock?
As of the end of day on the Jul 29, 2026, the price of an X4 Pharmaceuticals Inc. (XFOR) share was $4.00.

What is the 52-week high and low for X4 Pharmaceuticals Inc. Stock?
The 52-week high for X4 Pharmaceuticals Inc. Stock is $4.83 and the 52-week low is $1.35.

What is the market capitalization of X4 Pharmaceuticals Inc. Stock?
As of the Jul 29, 2026, the market capitalization of X4 Pharmaceuticals Inc. is 377.279M.

When is the next earnings date for X4 Pharmaceuticals Inc.?
The upcoming earnings date for X4 Pharmaceuticals Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT X4 PHARMACEUTICALS INC.
X4 Pharmaceuticals
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and my...
GOLDEN STAR
Ticker Change Signal Date
BIIB
$202.19
1.69% Jul 24
A
AVS
$7.74
0.388% Jul 24
IMMR
$6.60
16.06% Jul 23
S
SW
$43.71
16.22% Jul 23
TSCO
$30.32
3.76% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE